ID   PRDX3_HUMAN             Reviewed;         256 AA.
AC   P30048; B2R7Z0; D3DRC9; E9PH29; P35690; Q0D2H1; Q13776; Q5T5V2;
AC   Q96HK4;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 3.
DT   10-MAY-2017, entry version 202.
DE   RecName: Full=Thioredoxin-dependent peroxide reductase, mitochondrial;
DE            EC=1.11.1.15;
DE   AltName: Full=Antioxidant protein 1;
DE            Short=AOP-1;
DE   AltName: Full=HBC189;
DE   AltName: Full=Peroxiredoxin III;
DE            Short=Prx-III;
DE   AltName: Full=Peroxiredoxin-3;
DE   AltName: Full=Protein MER5 homolog;
DE   Flags: Precursor;
GN   Name=PRDX3; Synonyms=AOP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Blood;
RX   PubMed=7733872; DOI=10.1042/bj3070377;
RA   Tsuji K., Copeland N.G., Jenkins N.A., Obinata M.;
RT   "Mammalian antioxidant protein complements alkylhydroperoxide
RT   reductase (ahpC) mutation in Escherichia coli.";
RL   Biochem. J. 307:377-381(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ARG-55; THR-218 AND
RP   ILE-234.
RG   NIEHS SNPs program;
RL   Submitted (NOV-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow, Skeletal muscle, Testis, Urinary bladder, and
RC   Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 63-72 (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=1286669; DOI=10.1002/elps.11501301201;
RA   Hochstrasser D.F., Frutiger S., Paquet N., Bairoch A., Ravier F.,
RA   Pasquali C., Sanchez J.-C., Tissot J.-D., Bjellqvist B., Vargas R.,
RA   Appel R.D., Hughes G.J.;
RT   "Human liver protein map: a reference database established by
RT   microsequencing and gel comparison.";
RL   Electrophoresis 13:992-1001(1992).
RN   [10]
RP   PROTEIN SEQUENCE OF 74-93; 149-166 AND 171-214 (ISOFORM 1), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [11]
RP   OVEROXIDATION AT CYS-108.
RX   PubMed=12059788; DOI=10.1042/BJ20020525;
RA   Wagner E., Luche S., Penna L., Chevallet M., van Dorsselaer A.,
RA   Leize-Wagner E., Rabilloud T.;
RT   "A method for detection of overoxidation of cysteines: peroxiredoxins
RT   are oxidized in vivo at the active-site cysteine during oxidative
RT   stress.";
RL   Biochem. J. 366:777-785(2002).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH MAP3K13.
RX   PubMed=12492477; DOI=10.1046/j.1432-1033.2003.03363.x;
RA   Masaki M., Ikeda A., Shiraki E., Oka S., Kawasaki T.;
RT   "Mixed lineage kinase LZK and antioxidant protein-1 activate NF-kappaB
RT   synergistically.";
RL   Eur. J. Biochem. 270:76-83(2003).
RN   [13]
RP   SUBUNIT.
RX   PubMed=17707404; DOI=10.1016/j.jmb.2007.07.018;
RA   Cao Z., Bhella D., Lindsay J.G.;
RT   "Reconstitution of the mitochondrial PrxIII antioxidant defence
RT   pathway: general properties and factors affecting PrxIII activity and
RT   oligomeric state.";
RL   J. Mol. Biol. 372:1022-1033(2007).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-91, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [15]
RP   INTERACTION WITH NEK6.
RX   PubMed=20873783; DOI=10.1021/pr100562w;
RA   Vaz Meirelles G., Ferreira Lanza D.C., da Silva J.C.,
RA   Santana Bernachi J., Paes Leme A.F., Kobarg J.;
RT   "Characterization of hNek6 interactome reveals an important role for
RT   its short N-terminal domain and colocalization with proteins at the
RT   centrosome.";
RL   J. Proteome Res. 9:6298-6316(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   INTERACTION WITH LRRK2, PHOSPHORYLATION AT THR-146, AND MUTAGENESIS OF
RP   THR-146.
RX   PubMed=21850687; DOI=10.1002/humu.21582;
RA   Angeles D.C., Gan B.H., Onstead L., Zhao Y., Lim K.L., Dachsel J.,
RA   Melrose H., Farrer M., Wszolek Z.K., Dickson D.W., Tan E.K.;
RT   "Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3
RT   exacerbating oxidative stress-induced neuronal death.";
RL   Hum. Mutat. 32:1390-1397(2011).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   CLEAVAGE OF TRANSIT PEPTIDE [LARGE SCALE ANALYSIS] AFTER HIS-61, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Involved in redox regulation of the cell. Protects
CC       radical-sensitive enzymes from oxidative damage by a radical-
CC       generating system. Acts synergistically with MAP3K13 to regulate
CC       the activation of NF-kappa-B in the cytosol.
CC       {ECO:0000269|PubMed:12492477}.
CC   -!- CATALYTIC ACTIVITY: 2 R'-SH + ROOH = R'-S-S-R' + H(2)O + ROH.
CC   -!- SUBUNIT: Dodecameric ring assembled from homodimeric units;
CC       disulfide-linked, upon oxidation. The rings have an approximate
CC       diameter of 150 A and a central hole of 70 A. 3-5% of the rings
CC       are interlocked by pairs. Binds MAP3K13. Interacts with NEK6.
CC       Interacts with LRRK2. {ECO:0000269|PubMed:12492477,
CC       ECO:0000269|PubMed:17707404, ECO:0000269|PubMed:20873783,
CC       ECO:0000269|PubMed:21850687}.
CC   -!- INTERACTION:
CC       Q9H8Y8:GORASP2; NbExp=3; IntAct=EBI-748336, EBI-739467;
CC       Q5S007:LRRK2; NbExp=12; IntAct=EBI-748336, EBI-5323863;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P30048-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P30048-2; Sequence=VSP_054050;
CC         Note=No experimental confirmation available. Gene prediction
CC         based on EST data.;
CC   -!- PTM: Phosphorylated by LRRK2; phosphorylation reduces perodixase
CC       activity. {ECO:0000269|PubMed:21850687}.
CC   -!- MISCELLANEOUS: The active site is the redox-active Cys-108
CC       oxidized to Cys-SOH. Cys-SOH rapidly reacts with Cys-229-SH of the
CC       other subunit to form an intermolecular disulfide with a
CC       concomitant homodimer formation. The enzyme may be subsequently
CC       regenerated by reduction of the disulfide by thioredoxin.
CC   -!- MISCELLANEOUS: Irreversibly inactivated by overoxidation of Cys-
CC       108 (to Cys-SO(3)H) upon oxidative stress.
CC   -!- SIMILARITY: Belongs to the AhpC/TSA family. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether transit peptide cleavage occurs
CC       after His-61 or Ala-62. Peptides have been found for both N-
CC       termini.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/prdx3/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D49396; BAA08389.1; -; mRNA.
DR   EMBL; AK313169; BAG35987.1; -; mRNA.
DR   EMBL; CR450344; CAG29340.1; -; mRNA.
DR   EMBL; BT020007; AAV38810.1; -; mRNA.
DR   EMBL; DQ298752; ABB84468.1; -; Genomic_DNA.
DR   EMBL; AL355861; CAI15802.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49399.1; -; Genomic_DNA.
DR   EMBL; BC002685; AAH02685.1; -; mRNA.
DR   EMBL; BC007062; AAH07062.1; -; mRNA.
DR   EMBL; BC008435; AAH08435.1; -; mRNA.
DR   EMBL; BC009601; AAH09601.1; -; mRNA.
DR   EMBL; BC021691; AAH21691.1; -; mRNA.
DR   EMBL; BC022373; AAH22373.1; -; mRNA.
DR   EMBL; BC059169; AAH59169.1; -; mRNA.
DR   EMBL; BC111397; AAI11398.1; -; mRNA.
DR   CCDS; CCDS7611.1; -. [P30048-1]
DR   RefSeq; NP_001289201.1; NM_001302272.1.
DR   RefSeq; NP_006784.1; NM_006793.4. [P30048-1]
DR   UniGene; Hs.523302; -.
DR   PDB; 5JCG; X-ray; 2.80 A; A/B/C/D/E/F/G/H/I=62-256.
DR   PDBsum; 5JCG; -.
DR   ProteinModelPortal; P30048; -.
DR   SMR; P30048; -.
DR   BioGrid; 116136; 64.
DR   DIP; DIP-33600N; -.
DR   IntAct; P30048; 57.
DR   MINT; MINT-195453; -.
DR   STRING; 9606.ENSP00000298510; -.
DR   PeroxiBase; 4492; Hs2CysPrx03.
DR   iPTMnet; P30048; -.
DR   PhosphoSitePlus; P30048; -.
DR   SwissPalm; P30048; -.
DR   DMDM; 2507171; -.
DR   OGP; P30048; -.
DR   SWISS-2DPAGE; P30048; -.
DR   UCD-2DPAGE; P30048; -.
DR   EPD; P30048; -.
DR   MaxQB; P30048; -.
DR   PaxDb; P30048; -.
DR   PeptideAtlas; P30048; -.
DR   PRIDE; P30048; -.
DR   TopDownProteomics; P30048-1; -. [P30048-1]
DR   DNASU; 10935; -.
DR   Ensembl; ENST00000298510; ENSP00000298510; ENSG00000165672. [P30048-1]
DR   GeneID; 10935; -.
DR   KEGG; hsa:10935; -.
DR   UCSC; uc001lec.5; human. [P30048-1]
DR   CTD; 10935; -.
DR   DisGeNET; 10935; -.
DR   GeneCards; PRDX3; -.
DR   H-InvDB; HIX0035477; -.
DR   HGNC; HGNC:9354; PRDX3.
DR   HPA; CAB008656; -.
DR   HPA; HPA041488; -.
DR   MIM; 604769; gene.
DR   neXtProt; NX_P30048; -.
DR   OpenTargets; ENSG00000165672; -.
DR   PharmGKB; PA33724; -.
DR   eggNOG; KOG0852; Eukaryota.
DR   eggNOG; COG0450; LUCA.
DR   GeneTree; ENSGT00390000004653; -.
DR   HOVERGEN; HBG000286; -.
DR   InParanoid; P30048; -.
DR   KO; K20011; -.
DR   OMA; TQHAPAF; -.
DR   OrthoDB; EOG091G0IE5; -.
DR   PhylomeDB; P30048; -.
DR   TreeFam; TF105181; -.
DR   Reactome; R-HSA-3299685; Detoxification of Reactive Oxygen Species.
DR   ChiTaRS; PRDX3; human.
DR   GeneWiki; PRDX3; -.
DR   GenomeRNAi; 10935; -.
DR   PRO; PR:P30048; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000165672; -.
DR   CleanEx; HS_PRDX3; -.
DR   Genevisible; P30048; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005769; C:early endosome; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0008785; F:alkyl hydroperoxide reductase activity; NAS:UniProtKB.
DR   GO; GO:0043027; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; IMP:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0019900; F:kinase binding; IPI:UniProtKB.
DR   GO; GO:0008022; F:protein C-terminus binding; IPI:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0008379; F:thioredoxin peroxidase activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0045454; P:cell redox homeostasis; IEA:InterPro.
DR   GO; GO:0034599; P:cellular response to oxidative stress; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0034614; P:cellular response to reactive oxygen species; IMP:UniProtKB.
DR   GO; GO:0042744; P:hydrogen peroxide catabolic process; IDA:MGI.
DR   GO; GO:0001893; P:maternal placenta development; IEA:Ensembl.
DR   GO; GO:0007005; P:mitochondrion organization; IMP:UniProtKB.
DR   GO; GO:0030099; P:myeloid cell differentiation; ISS:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0033673; P:negative regulation of kinase activity; IDA:UniProtKB.
DR   GO; GO:0018171; P:peptidyl-cysteine oxidation; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0051881; P:regulation of mitochondrial membrane potential; IMP:UniProtKB.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IDA:UniProtKB.
DR   GO; GO:0032496; P:response to lipopolysaccharide; ISS:UniProtKB.
DR   GO; GO:0006979; P:response to oxidative stress; IMP:UniProtKB.
DR   GO; GO:0000302; P:response to reactive oxygen species; TAS:Reactome.
DR   InterPro; IPR000866; AhpC/TSA.
DR   InterPro; IPR019479; Peroxiredoxin_C.
DR   InterPro; IPR012336; Thioredoxin-like_fold.
DR   InterPro; IPR013766; Thioredoxin_domain.
DR   Pfam; PF10417; 1-cysPrx_C; 1.
DR   Pfam; PF00578; AhpC-TSA; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   PROSITE; PS51352; THIOREDOXIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Antioxidant;
KW   Complete proteome; Direct protein sequencing; Disulfide bond;
KW   Mitochondrion; Oxidoreductase; Peroxidase; Phosphoprotein;
KW   Polymorphism; Redox-active center; Reference proteome;
KW   Transit peptide.
FT   TRANSIT       1     61       Mitochondrion.
FT                                {ECO:0000244|PubMed:25944712}.
FT   CHAIN        62    256       Thioredoxin-dependent peroxide reductase,
FT                                mitochondrial.
FT                                /FTId=PRO_0000023782.
FT   DOMAIN       63    221       Thioredoxin. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00691}.
FT   ACT_SITE    108    108       Cysteine sulfenic acid (-SOH)
FT                                intermediate. {ECO:0000250}.
FT   MOD_RES      83     83       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P20108}.
FT   MOD_RES      91     91       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      91     91       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P20108}.
FT   MOD_RES     146    146       Phosphothreonine.
FT                                {ECO:0000305|PubMed:21850687}.
FT   DISULFID    108    108       Interchain (with C-229); in linked form.
FT                                {ECO:0000250}.
FT   DISULFID    229    229       Interchain (with C-108); in linked form.
FT                                {ECO:0000250}.
FT   VAR_SEQ      51     68       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_054050.
FT   VARIANT      55     55       S -> R (in dbSNP:rs34698541).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_025052.
FT   VARIANT     170    170       R -> Q (in dbSNP:rs11554902).
FT                                /FTId=VAR_059546.
FT   VARIANT     218    218       A -> T (in dbSNP:rs36064375).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_025053.
FT   VARIANT     234    234       T -> I (in dbSNP:rs35697338).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_025054.
FT   MUTAGEN     146    146       T->A: Impairs phosphorylation.
FT                                {ECO:0000269|PubMed:21850687}.
FT   CONFLICT     31     31       R -> W (in Ref. 8; AAH08435).
FT                                {ECO:0000305}.
FT   STRAND       73     78       {ECO:0000244|PDB:5JCG}.
FT   STRAND       81     86       {ECO:0000244|PDB:5JCG}.
FT   HELIX        87     90       {ECO:0000244|PDB:5JCG}.
FT   STRAND       93     99       {ECO:0000244|PDB:5JCG}.
FT   HELIX       107    117       {ECO:0000244|PDB:5JCG}.
FT   HELIX       119    123       {ECO:0000244|PDB:5JCG}.
FT   TURN        124    126       {ECO:0000244|PDB:5JCG}.
FT   STRAND      127    135       {ECO:0000244|PDB:5JCG}.
FT   HELIX       137    144       {ECO:0000244|PDB:5JCG}.
FT   HELIX       148    150       {ECO:0000244|PDB:5JCG}.
FT   STRAND      157    162       {ECO:0000244|PDB:5JCG}.
FT   STRAND      164    166       {ECO:0000244|PDB:5JCG}.
FT   HELIX       167    171       {ECO:0000244|PDB:5JCG}.
FT   TURN        177    180       {ECO:0000244|PDB:5JCG}.
FT   STRAND      184    189       {ECO:0000244|PDB:5JCG}.
FT   STRAND      193    201       {ECO:0000244|PDB:5JCG}.
FT   HELIX       209    225       {ECO:0000244|PDB:5JCG}.
FT   TURN        244    247       {ECO:0000244|PDB:5JCG}.
FT   HELIX       248    253       {ECO:0000244|PDB:5JCG}.
SQ   SEQUENCE   256 AA;  27693 MW;  8BEB7F5E55BFE9BE CRC64;
     MAAAVGRLLR ASVARHVSAI PWGISATAAL RPAACGRTSL TNLLCSGSSQ AKLFSTSSSC
     HAPAVTQHAP YFKGTAVVNG EFKDLSLDDF KGKYLVLFFY PLDFTFVCPT EIVAFSDKAN
     EFHDVNCEVV AVSVDSHFSH LAWINTPRKN GGLGHMNIAL LSDLTKQISR DYGVLLEGSG
     LALRGLFIID PNGVIKHLSV NDLPVGRSVE ETLRLVKAFQ YVETHGEVCP ANWTPDSPTI
     KPSPAASKEY FQKVNQ
//
